Breast cancer remains the most common cancer among women in Malaysia, with recent data indicating an increase in both incidence and late-stage diagnoses. According to the National Cancer Registry, 29,534 breast cancer cases were recorded between 2017 and 2021, with a rise in lifetime risk for Malaysian women from one in 27 to one in 23 compared to the previous five years.
Health authorities have raised concerns over the growing proportion of late-stage detections. Of cases with documented staging, just over half (50.5%) were diagnosed at stage 3 or 4, a rise from 43% during 2007 to 2011. Early-stage diagnoses (stage 1) have simultaneously declined from about 20% to 15%. Preliminary figures for 2022 and 2023 suggest this trend towards late diagnosis is ongoing.
Early detection significantly improves outcomes. A Health Ministry survival study involving more than 17,000 women found that five-year survival rates were 87.5% for those diagnosed at stage 1, dropping sharply to 23.3% at stage 4. Overall survival in Malaysia stands at 66.8%, notably lower than rates reported in countries such as Japan, South Korea, and Singapore. Survival rates also vary by ethnicity, with 57.9% among Malay women and 76.5% among Chinese women.
National guidelines recommend biennial mammograms for women aged 50 to 74 at average risk, with more frequent and earlier screening advised for those at higher risk. Additionally, annual clinical breast examinations are recommended beginning at age 40. However, data from 2016 to 2020 show that only approximately 25% of women eligible for clinical breast examinations received them annually.
Efforts to expand screening access include subsidised mammograms through Klinik Nur Sejahtera clinics managed by the National Population and Family Development Board (LPPKN), and free screening services provided by organizations such as the National Cancer Council (Makna) and the National Cancer Society Malaysia. Health officials emphasize the importance of seeking prompt medical attention for symptoms like new lumps, skin changes, nipple discharge, or dimpling regardless of age.
Family support proves vital both before and after diagnosis. Studies among rural Malaysian women indicate that encouragement from family members, particularly husbands, influences the likelihood of attending screening. Cultural and logistical barriers, including discomfort with male doctors, fears related to mastectomy, and childcare responsibilities, were cited as impediments. After diagnosis, social isolation correlates with substantially poorer survival, underscoring the value of ongoing emotional and practical support.
Despite years of awareness campaigns, the proportion of late-stage breast cancer diagnoses has not declined significantly. Experts call for structural reforms to improve early detection rates, including transitioning from opportunistic to organised screening programs. Such programs would involve personalized invitations and follow-ups for non-attendees, potentially utilising existing health platforms like MySejahtera.
Integrating screening services across government agencies and NGOs is also recommended, along with establishing a shared registry linked to the National Cancer Registry to identify gaps in coverage. Reducing delays between abnormal screening results and treatment through the publication of time-to-diagnosis and time-to-treatment standards, expanding one-stop breast clinics, and funding patient navigators—particularly in rural areas—are seen as critical measures.
Additional policy considerations include offering subsidized genetic counselling and BRCA gene testing for women with strong family histories, as well as addressing modifiable risk factors such as obesity, alcohol consumption, tobacco use, and physical inactivity. Support for breastfeeding in workplaces is highlighted as a preventive strategy.
The emphasis remains on improving early detection and ensuring no woman faces breast cancer in isolation, with hopes that forthcoming registry data will show a reduction in advanced-stage diagnoses.